What Happened?
Boston, MA-based Atea-Pharmaceuticals Appointed Jean Sommadossi as Chairman and Chief Executive Officer
Date of management change: July 15, 2019
Boston, MA-based Atea-Pharmaceuticals Appointed Jean Sommadossi as Chairman and Chief Executive Officer
Atea Pharmaceuticals is a clinical stage biopharmaceutical company focused on discovering, developing and commercializing therapies to address the unmet medical needs of patients with life-threatening viral diseases. Leveraging the Company`s deep understanding of antiviral drug development, nucleoside biology, and medicinal chemistry, Atea has built a proprietary nucleotide prodrug platform to develop novel product candidates to treat single stranded ribonucleic acid, or ssRNA, viruses, which are a prevalent cause of severe viral diseases. Currently, Atea is focused on the development of orally-available, potent, and selective nucleotide prodrugs for difficult-to-treat, life-threatening viral infections, including severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes COVID-19, dengue virus, hepatitis C virus (HCV) and respiratory syncytial virus (RSV).
Jean Sommadossi is Chairman and Chief Executive Officer at Atea Pharmaceuticals. Previously, Jean held various senior HR leadership roles in the industry.
News
Other IT executives who recently changed jobs as well: Sturm Jackie, Haberkorn David, Ferguson Gray Trixie, Martinez Edith, Weir Natalie, McMahan Danielle, Batin Dennis, Montieth Katina, Kushman Shay, Hansen Kris, Stephen Doug
You can find the full directory of IT executives here.
How would you like to connect with 15,000+ IT executives in charge of $ millions in IT budgets? Find details here.